220 related articles for article (PubMed ID: 15571510)
21. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
22. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
23. Brain lesions in tuberous sclerosis complex. Review.
Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
[TBL] [Abstract][Full Text] [Related]
24. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
25. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
26. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
27. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
Johnson MW; Emelin JK; Park SH; Vinters HV
Brain Pathol; 1999 Jan; 9(1):45-54. PubMed ID: 9989450
[TBL] [Abstract][Full Text] [Related]
28. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.
Nguyen-Vu PA; Fackler I; Rust A; DeClue JE; Sander CA; Volkenandt M; Flaig M; Yeung RS; Wienecke R
J Cutan Pathol; 2001 Oct; 28(9):470-5. PubMed ID: 11553313
[TBL] [Abstract][Full Text] [Related]
29. The tuberous sclerosis complex model Eker (TSC2+/-) rat exhibits hyperglycemia and hyperketonemia due to decreased glycolysis in the liver.
Aizawa Y; Shirai T; Kobayashi T; Hino O; Tsujii Y; Inoue H; Kazami M; Tadokoro T; Suzuki T; Kobayashi KI; Yamamoto Y
Arch Biochem Biophys; 2016 Jan; 590():48-55. PubMed ID: 26550928
[TBL] [Abstract][Full Text] [Related]
30. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
31. Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia.
Kútna V; Uttl L; Waltereit R; Krištofiková Z; Kaping D; Petrásek T; Hoschl C; Ovsepian SV
Neurotherapeutics; 2020 Jan; 17(1):329-339. PubMed ID: 31820275
[TBL] [Abstract][Full Text] [Related]
32. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
Cheng S; Hawkins C; Taylor MD; Bartels U
Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
[TBL] [Abstract][Full Text] [Related]
33. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.
Crino PB; Trojanowski JQ; Dichter MA; Eberwine J
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14152-7. PubMed ID: 8943076
[TBL] [Abstract][Full Text] [Related]
34. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
35. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
36. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex.
Kyin R; Hua Y; Baybis M; Scheithauer B; Kolson D; Uhlmann E; Gutmann D; Crino PB
Am J Pathol; 2001 Oct; 159(4):1541-54. PubMed ID: 11583980
[TBL] [Abstract][Full Text] [Related]
37. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
38. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.
Henske EP; Wessner LL; Golden J; Scheithauer BW; Vortmeyer AO; Zhuang Z; Klein-Szanto AJ; Kwiatkowski DJ; Yeung RS
Am J Pathol; 1997 Dec; 151(6):1639-47. PubMed ID: 9403714
[TBL] [Abstract][Full Text] [Related]
39. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
[TBL] [Abstract][Full Text] [Related]
40. Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product.
Pajak L; Jin F; Xiao GH; Soonpaa MH; Field LJ; Yeung RS
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1619-27. PubMed ID: 9321857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]